Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients

被引:0
|
作者
Ajmi, M. [1 ,2 ]
Sahtout, W. [3 ]
Omezzine, A. [1 ,4 ]
Amor, D. [1 ]
Abderahmene, A. [1 ,4 ]
Azzabi, A. [3 ]
Ben-Rejeb, N. [1 ,4 ]
Achour, A. [3 ]
Bouslama, A. [1 ,4 ]
机构
[1] Sahloul Univ Hosp, Dept Biochem, LR12SP11, Sousse, Tunisia
[2] Higher Inst Biotechnol Monastir, Sousse, Tunisia
[3] Sahloul Univ Hosp, Dept Nephrol, Sousse, Tunisia
[4] Univ Monastir, Fac Pharm, Sousse, Tunisia
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PS2 - 050
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [21] CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
    Kurzawski, Mateusz
    Dabrowska, Justyna
    Dziewanowski, Krzysztof
    Domanski, Leszek
    Peruzynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2014, 15 (02) : 179 - 188
  • [22] Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients
    Yildirim, Engin
    Sahin, Garip
    Kaltus, Zuhal
    Colak, Ertugrul
    CLINICAL LABORATORY, 2019, 65 (11) : 2079 - 2089
  • [23] Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation
    Turolo, Stefano
    Tirelli, Amedea S.
    Ferraresso, Mariano
    Ghio, Luciana
    Belingheri, Mirco
    Groppali, Elena
    Torresani, Erminio
    Edefonti, Alberto
    PHARMACOLOGICAL REPORTS, 2010, 62 (06) : 1159 - 1169
  • [24] Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
    Romain Guilhaumou
    Caroline Solas
    Veronique Bourgarel-Rey
    Sylvie Quaranta
    Angelique Rome
    Nicolas Simon
    Bruno Lacarelle
    Nicolas Andre
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 1633 - 1638
  • [25] Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation
    Stefano Turolo
    Amedea S. Tirelli
    Mariano Ferraresso
    Luciana Ghio
    Mirco Belingheri
    Elena Groppali
    Erminio Torresani
    Alberto Edefonti
    Pharmacological Reports, 2010, 62 : 1159 - 1169
  • [26] Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
    Guilhaumou, Romain
    Solas, Caroline
    Bourgarel-Rey, Veronique
    Quaranta, Sylvie
    Rome, Angelique
    Simon, Nicolas
    Lacarelle, Bruno
    Andre, Nicolas
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1633 - 1638
  • [27] Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients
    Ho, Teresa T.
    Perkins, Janelle B.
    Gonzalez, Rebecca
    Hicks, James Kevin
    Martinez, Ronald Alvarez
    Duranceau, Katie
    North, Brianna
    Kim, Jongphil
    Teer, Jamie K.
    Yao, Jiqiang
    Yoder, Sean J.
    Nishihori, Taiga
    Bejanyan, Nelli
    Pidala, Joseph
    Elmariah, Hany
    PHARMACOGENOMICS, 2024, 25 (01) : 29 - 40
  • [28] EFFECT OF CYP3A4*22, CYP3A5*3 AND ABCB1 C3435T ON TACROLIMUS METABOLISMIN LEBANESE RENAL TRANSPLANT PATIENTS: A RETROSPECTIVE STUDY
    Antoun, Stephanie
    Zouroub, Nahil
    Sadek, Zahraa
    Irani, Jihad
    Abou Jaoude, Maroun
    Chalhoub, Elias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 361 - 361
  • [29] Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients
    Genvigir, Fabiana D. V.
    Salgado, Patricia C.
    Felipe, Claudia R.
    Luo, Elena Y. F.
    Alves, Camila
    Cerda, Alvaro
    Tedesco-Silva, Helio, Jr.
    Medina-Pestana, Jose O.
    Oliveira, Nagilla
    Rodrigues, Alice C.
    Doi, Sonia Q.
    Hirata, Mario H.
    Hirata, Rosario D. C.
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (10): : 462 - 472
  • [30] Influence of Combined CYP3A4/CYP3A5 Polymorphisms on Tacrolimus Pharmacokinetic in Tunisian Renal Graft Patients
    Hannachi, I.
    Ben-Fredj, N.
    Chadli, Z.
    Kerkeni, E.
    Ben-Romadhane, H.
    Ben-Fadhel, N.
    Woillard, J. B.
    Boughattas, N. A.
    Aouam, K.
    Chaabane, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 75 - 75